GSK comes home for £1.4bn after five year absence
GlaxoSmithKline, the UK pharmaceutical company, launched its first sterling bonds today for nearly five years, achieving strong demand and raising £1.4bn in the second biggest corporate issue of the year in the currency.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts